GCGesa Carstens

Gesa Carstens

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gesa Carstens has a total of 55 co-authors. Here are the top co-authors by number of shared publications:

  • Albert Jan van Hoek

    Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands

    9 shared publications
  • Wanda Han

    Dutch National Institute for Public Health and the Environment (RIVM), Centre for Infectious Disease Control (CIb), Bilthoven, the Netherlands

    7 shared publications
  • Dirk Eggink

    Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, Netherlands

    6 shared publications
  • Jordy de Bakker

    Affiliation Dutch National Institute for Public Health and the Environment (RIVM), Centre for Infectious Disease Control (CIb), Bilthoven, The Netherlands

    5 shared publications
  • Mansoer Elahi

    Affiliation Dutch National Institute for Public Health and the Environment (RIVM), Centre for Infectious Disease Control (CIb), Bilthoven, The Netherlands

    5 shared publications
  • Susan van Den Hof

    Centre for infectious disease control, National institute for public health and the environment (RIVM), Bilthoven, the Netherlands

    5 shared publications

Latest Publications

  • Open Access

    Population-level associations in the spread of co-circulating respiratory viruses: A multi-method statistical investigation using incidence data

    by Nadine Barth, Gesa Carstens, Eva Kozanli, Wanda Han, Lisa Hermans, Daniela Paolotti, Steven Abrams, Geert Molenberghs, Niel Hens, Christel Faes, et al.

  • Open Access

    Decomposing Participatory Surveillance Symptom Time Series to Track Respiratory Infections: A Cross-Country Evaluation Using Non-Negative Matrix Factorization

    by Gesa Carstens, Mattia Mazzoli, Nicolo Gozzi, Albert Jan van Hoek, Daniela Paolotti

    Background: The annual respiratory season in Europe is marked by the co-circulation of multiple respiratory pathogens, such as influenza viruses, rhinoviruses, and coronaviruses. Effective surveillance is necessary but hampered by heterogeneity of case definitions and limited pathogen specificity in existing systems. This study aims to detect pathogen-specific signals in the participatory surveillance of the Netherlands using a sub-set of samples with virological detection. Additionally, we explore a method to use the findings in the Netherlands to enhance the virological interpretation of participatory surveillance data in Italy. Methods: We analyzed symptom data collected through a participatory surveillance platform in the Netherlands and Italy over five years (2020–2025). Symptom-by-week matrices from the Dutch cohort were aggregated into syndromes and their associated time series using Non-negative Matrix Factorization (NMF). We compared the respective time series of the syndromes with influenza virus, SARS-CoV-2, seasonal coronaviruses, RSV, and rhinovirus incidence estimated from nose- and throat swabs of a subsample of symptomatic participants of the participatory surveillance platform in the Netherlands. We tested the transferability of these components by applying the Dutch-derived components to describe Italian symptom data and extract respective incidences. Results: NMF identified eight symptom clusters in the Dutch cohort, one aligning with SARS-CoV-2, one aligning with rhinovirus and a third component aligning with influenza virus, RSV and seasonal incidences estimated from collected nose- and throat swabs. Transferring Dutch-derived symptom clusters to Italian data showed consistency in key components between Dutch and Italian cohorts, particularly those associated with SARS-CoV-2. Conclusion: This study demonstrates that unsupervised symptom decomposition can identify co-circulating respiratory pathogens trends from syndromic surveillance data, providing timely pathogen circulation insights. Graphical

  • Open Access

    Population-Level Associations in the Spread of Co-Circulating Respiratory Viruses: A Multi-Method Statistical Investigation Using Incidence Data

    by Nadine Barth, Gesa Carstens, Eva Kozanli, Wanda Han, Lisa Hermans, Daniela Paolotti, Steven Abrams, Geert Molenberghs, Niel Hens, Christel Faes, et al.

    Respiratory infections remain a major global health burden, causing substantial morbidity and mortality worldwide. The responsible viruses circulate concurrently, potentially affecting each other’s dynamics, yet the extent and direction of such interactions remain poorly understood. Characterising these cross-pathogen effects at the population level is essential for elucidating transmission dynamics and guiding mitigation strategies. Using incidence data from a participatory syndromic surveillance system with multiplex PCR confirmation of specific pathogens, we applied complementary statistical approaches, including multivariate regression, endemic–epidemic, and distributed-lag models, to characterise immediate and delayed associations among seven major respiratory diseases. We show that these pathogens form a connected system in which some, such as SARS-CoV-2 and human seasonal coronaviruses, enhance each other’s transmission, whereas others, notably influenza, inhibit the concurrent circulation of competitors such as rhinovirus or parainfluenza virus. Effects were often directional rather than reciprocal: for instance, rhinovirus inhibited human seasonal coronaviruses but not vice versa, while mutual enhancement between human metapneumovirus and parainfluenza virus appeared across several models. Interaction patterns were time-dependent yet largely consistent, indicating persistent ecological interference among co-circulating respiratory viruses. By integrating multiple analytic frameworks, our study provides a comprehensive, data-driven view of how respiratory viruses coexist and compete, offering crucial insights for improved epidemic forecasting and mitigation strategies.


  • Open Access

    Emergence of COVID-19 Variant XFG not linked to Higher Rates of Sore Throat or altered severity: Evidence from participatory surveillance in The Netherlands

    by Gesa Carstens, Eva Kozanli, Wanda Han, Marie Gruters, Rianne van Gageldonk, Susan van Den Hof, Albert Jan van Hoek, Dirk Eggink

    Since the emergence of SARS-CoV-2, the virus causing COVID-19, it evolved into different lineages and sub-variants. New genetic variants of the virus can result in a different transmissibility, immune evasion, as well as different symptoms and severity of disease. When new variants appear, media report often anecdotal observations of unique or differentiating symptomatology of these new variants. Here, we investigate reported elevated levels of sore throat linked to the new variant XFG using an evidence-based method.


  • Open Access

    Longitudinal trends in the endemic symptomatic burden of COVID-19: Insights from community-based participatory virological surveillance in the Netherlands, November 2020 - April 2025

    by Gesa Carstens, Wanda Han, Luisa Timmermans, Susan van Den Hof, Dirk Eggink, Albert Jan van Hoek

    Objectives: To analyze changes over time in symptomatology and symptom burden of SARS-CoV-2 infected individuals. Methods: Data from symptomatic individuals from Infectieradar, an online community-based, participatory surveillance platform in the Netherlands, were analyzed (November 2020 - April 2025). Weekly questionnaires collected self-reported data on SARS-CoV-2 testing, health score (scale: 0-100), medication use, and healthcare visits. Longitudinal trends were evaluated using logistic regression models adjusted for age, sex, and comorbidities. Results: During 4.5 years, 18,600 participants reported a positive SARS-CoV-2 test at least once. Upper respiratory symptoms became more prominent over time, and loss of smell and taste less. The self-reported health score and the proportion of symptomatic SARS-CoV-2-positive individuals with a high number of symptoms (more than 10 symptoms) remained relatively stable over time (October 2022 - April 2025), with a health impact comparable to influenza virus infections (n = 768). Conclusions: The findings suggest that the clinical presentation of COVID-19 has evolved toward upper respiratory symptoms. Despite shifting symptoms, the impact on reported well-being in this population was remarkably stable, without a significantly lower endemic symptomatic burden. The health impact of COVID-19 is more comparable to influenza than to other common respiratory infections.


  • Open Access

    Healthcare-seeking behavior and hidden influenza-like-illness across the COVID-19 pandemic: a multi-country participatory surveillance study

    by Mattia Mazzoli, Nicolò Gozzi, Lisa Hermans, Niel Hens, Gesa Carstens, Albert Jan van Hoek, Audrey Le Hegaret, Caroline Guerrisi, Clément Turbelin, Marion Debin, et al.

    Assessing healthcare seeking behavior is critical to estimate Influenza-like-illness (ILI) burden, i.e., the fraction of population infected, and inform vaccination campaigns for Influenza, SARS-CoV-2 and RSV, aimed at reducing disease circulation and severe illness. The Covid-19 pandemic put national healthcare systems under stress, affecting surveillance and healthcare seeking behavior of patients across demographic groups and countries. The under-reporting of influenza sentinel surveillance due to patients not consulting healthcare centers hinders consistent influenza burden estimates and hampers the understanding of influenza transmission at the international level. We leveraged an online participatory surveillance platform, InfluenzaNet, collecting data in six European countries, to study how the pandemic impacted individual healthcare seeking behavior in ILI patients and to estimate age-specific burden of ILI cases in terms of seasonal attack rates in the digital cohorts, hence including individuals who did not visit healthcare services. We studied drivers of healthcare seeking behavior such as demographics, socio-economic traits, comorbidities, duration and severity of symptoms, education and work status via a logistic regression model adjusted by age and sex of national populations, correcting for sampling biases. The presence of comorbidities, the duration and severity of the symptoms, and the self-assessed cause of symptoms, reflecting patients’ self-diagnosis, were drivers for health-seeking behavior consistently found across most countries, before and during the COVID-19 pandemic. The pandemic instead had a country-specific impact on age, gender, education and labor as determinants of healthcare seeking behavior throughout the crisis. We estimated ILI burden across countries using a standardized case definition, and assessed the burden of ILI that went undetected due to individuals not seeking healthcare from the general practitioner (GP, family physician) or other services. Our work highlights the advantage of integrating traditional systems with online participatory surveillance, which captures healthcare seeking behavior and helps to better assess the impact of pandemics on respiratory illnesses circulation. Further adoption of these tools has the potential to favor EU-level respiratory diseases surveillance, vaccination guidelines for Influenza, RSV and SARS-CoV-2 and a deeper understanding and management of ILI epidemiology and impact. Evidence before this study Before the SARS-CoV-2 pandemic, age, gender, education, the self-assessed cause of symptoms, their severity and duration were identified as known predictors of healthcare seeking behavior due to influenza-like-illness. However, most studies on population attendance to medical service focused on single countries, without assessing the robustness of these predictors across countries. Furthermore, it is not known what the impact of the pandemic was on their significance. Assessing healthcare seeking behavior is critical to estimate the burden of influenza-like-illness and inform decisions on the roll out of vaccination campaigns. We performed a literature search on Google Scholar using the keywords “ healthcare seeking behavior”, “ILI burden estimate”, “influenza-like-illness burden”, “burden estimate”, “ILI burden”, with no time limits, in the English language. Added value of this study Our study highlights the value of cross-country analyses by showing that not all known predictors of healthcare seeking behavior were robust across countries. Self-assessed cause of symptoms, their severity and duration proved robust across countries and pre-pandemic and pandemic periods except where small sample sizes prevented detection of significant effects. On the other hand, the pandemic had country-specific impact on socio-demographic predictors like age, gender, education and labor. Our work highlights substantial underdetection of ILI cases with respect to those estimated by national sentinel surveillance in all countries. Implications of all the available evidence This work suggests that the pandemic did not alter healthcare seeking behavior known predictors related to symptoms duration, severity and self-assessed cause, while we observed country-specific effects on age, gender and education factors. Digital cohorts may play a decisive role in integrating surveillance systems across countries for the estimation of ILI burden including medically unattended patients.

  • Open Access

    Flexible and scalable participatory syndromic and virological surveillance for respiratory infections: Our experiences in The Netherlands

    by Tara Smit, Gesa Carstens, Wanda Han, Kirsten Bulsink, Jordy de Bakker, Mansoer Elahi, Rianne van Gageldonk-Lafeber, Susan van Den Hof, Dirk Eggink, Albert Jan van Hoek

    Background: During the COVID-19 pandemic participatory digital surveillance of symptoms (syndromic surveillance) re-established itself as a worthy addition to the surveillance pyramid, as they are scalable, flexible and function independent from the health care system or health care seeking behaviour. A limitation of syndromic surveillance however is the inability of pathogen identification. We describe our experiences regarding integrating self-swabs with centralized testing into a participatory syndromic surveillance system in the Netherlands (Infectieradar). Methods: In the 2022/2023 winter season Infectieradar was extended to include nose- and throat swabs. Participants received test-kits including SARS-CoV-2 antigen tests for home use as well as nose- and throat swabs. All SARS-CoV-2 positive participants and a random sample of symptomatic SARS-CoV-2 self-test negative participants were asked to return a nose- and throat swab by regular post. Self-test negative swabs were tested by multiplex-PCR on 22 pathogens, including SARS-CoV-2. Self-test SARS-CoV-2 positive samples with a Ct-value < 30 were sequenced for variant analysis. Results: Over 17,000 participants were included in the study, which involved relatively older persons and relatively more women compared to the general Dutch population. We collected 1,475 (median: 37 per week) swabs from participants with positive and 4,096 swabs (median: 136 per week) from participants with negative SARS-CoV-2 antigen self-tests (74% of those who requested to send in a swab). Of the swabs following a negative self-test, 47.7% tested positive in the multiplex-PCR, with rhinovirus/enterovirus being the most frequently detected pathogen (24.5%). Self-test SARS-CoV-2 positivity was laboratory-confirmed in 96.1% of swabs and showed parallel variant distributions as the national SARS-CoV-2 variant surveillance. Conclusion: This large-scale, centralized participatory surveillance system provides a comprehensive approach for performing syndromic and virological surveillance in the general population, including respiratory pathogen detection by self-test or multiplex-PCR. Despite the non-representative sample it was possible to monitor the variant distribution. Given the continuous collection of samples among those who don’t seek care, the system provides valuable insights into circulating respiratory pathogens and is part of an answer on how to study the transmission, competition, virulence and evolution of circulating pathogens in interpandemic periods.


  • Open Access

    Co-infection dynamics of SARS-CoV-2 and respiratory viruses in the 2022/2023 respiratory season in the Netherlands

    by Gesa Carstens, Eva Kozanli, Kirsten Bulsink, Scott A. McDonald, Mansoer Elahi, Jordy de Bakker, Maarten Schipper, Rianne van Gageldonk-Lafeber, Susan van Den Hof, Albert Jan van Hoek, et al.


  • Open Access

    Co-infection dynamics of SARS-CoV-2 and respiratory viruses in the 2022/2023 respiratory season in the Netherlands

    by Gesa Carstens, Eva Kozanli, Kirsten Bulsink, Scott McDonald, Mansoer Elahi, Jordy de Bakker, Maarten Schipper, Rianne van Gageldonk-Lafeber, Susan van Den Hof, Albert Jan van Hoek, et al.

    Objectives Evaluation of the presence and effect of SARS-CoV-2 co-infections on disease severity. Methods We collected both symptom data and nose- and throat samples from symptomatic people during the 2022/2023 respiratory season in a large participatory surveillance study in the Netherlands, and tested these for 18 respiratory viruses including SARS-CoV-2. We compared reported health status, symptoms and odds of having a mono respiratory viral infection or co-infection with SARS-CoV-2 and another respiratory virus. Results In total 4,655 samples were included with 22% (n=1,017) testing SARS-CoV-2 positive. Of these 11% (n=116) also tested positive for a second respiratory virus. The most frequently occurring co-infections in SARS-CoV-2 positive participants were with rhinovirus (59%; n=69), seasonal coronaviruses (15%; n=17) and adenovirus (7%; n=8). Participants with a co-infection with one of these three viruses did not report more severe disease compared to those with a SARS-CoV-2 mono-infection. The odds of experiencing SARS-CoV-2 co-infection with seasonal coronavirus or rhinovirus were lower compared to the odds of the respective non-SARS-CoV-2 mono-infection (OR: 0.16, CI 95%: 0.10 – 0.24; OR: 0.21 CI 95%: 0.17 – 0.26; respectively). Conclusions SARS-CoV-2 co-infections with rhinovirus, seasonal coronavirus and adenovirus are frequently observed in the general population, but are not associated with more severe disease compared to SARS-CoV-2 mono-infections. Furthermore, we found indications for inter-virus interaction with rhinovirus and seasonal coronavirus, possibly decreasing risk of co-infection. Highlights Our study showed viral co-infections in 11% of the SARS-CoV-2 positive participants SARS-CoV-2 mono-infections led to more severe symptoms than the common cold mono-infections with seasonal coronavirus or rhinovirus SARS-CoV-2 co-infections with common cold viruses did not lead to worse health status compared to SARS-CoV-2 mono-infections Odds for mono-infection with common cold virus were higher than for co-infection with SARS-CoV-2 and the respective common cold virus